NLS Pharmaceutics News

NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment With FDA Submission

TipRanksDec 19 21:57

NLS Pharmaceutics And Kadimastem In Collaboration With ITolerance Announced That Request For Pre-Investigational New Drug Meeting Has Been Submitted To The FDA For ITOL102 For Type 1 Diabetes

BenzingaDec 19 20:42

NLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders' Meeting

TipRanksDec 18 05:57

NLS Pharmaceutics Expects to Close Kadimastem Merger by End of January

Yahoo FinanceDec 12 20:45

NLS Pharmaceutics Advances DOXA Platform Amid Merger Plans

TipRanksDec 12 01:02

Which Subsectors to Own and Which to Avoid – Wolfe Research

Seeking AlphaDec 11 02:33

Protara Therapeutic TARA +77% Phase 2 Results; NLS Pharmaceutics NLSP -20% Private Placement

BioPharmCatalystDec 6 13:40

NLS Pharmaceutics Offers New Investment Opportunities

TipRanksDec 5 05:27

NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market

PR NewswireDec 5 02:15

NLS Pharmaceutics Shares Are Trading Higher After the Company Announced Preclinical Data for Its Non-sulfonamide, Dual Orexin Receptor Agonists for Potential Treatment of Narcolepsy and Neurological Disorders.

BenzingaDec 3 20:48

NLS Pharmaceutics Says Preclinical Data Demonstrate The Potential Of Its Dual Orexin Receptor Agonist Platform, An Investigational New Drug Application Is Planned For 2026-2027

BenzingaDec 3 20:46

Express News | NLS Pharmaceutics AG -Investigational New Drug (Ind) Application Is Planned for 2026-2027 for Study

BreakingsDec 3 20:44

Express News | NLS Pharmaceutics- Starting in 2025, NLS Plans to Expand Its Research to Investigate Impact on Ctsh in Animal Models of Neuroinflammation

BreakingsDec 3 20:43

NLS Pharmaceutics Unveils Promising Narcolepsy Treatment

TipRanksNov 18 21:59

NLS Pharmaceutics Announces Strategic Capital Restructuring

TipRanksNov 7 05:51

What's Going On With NLS Pharmaceutics Shares Monday?

BenzingaNov 5 03:00

Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

BenzingaNov 4 21:57

NLS Pharmaceutics NLSP Merger; Disc Medicine IRON Trial Design

BioPharmCatalystNov 4 21:50

NLS Pharmaceutics Enters Definitive Merger Agreement With Kadimastem; At Closing, NLS Will Issue Shares Of Its Common Stock To Kadimastem's Shareholders Based On An Initial Target Fully Diluted Share Split, Post Transaction, Of 85% To Kadimastem...

BenzingaNov 4 20:07

NLS Pharmaceutics Strikes Debt Forgiveness Deal

TipRanksOct 23 04:33